25.32
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses,…
Upon viral infection, cells secrete interferons to protect uninfected cells and activate the patrolling NK cells to initiate a non-specific innate immune response.
These NK cells have pathogen recognition receptors that recognize diverse viral antigens on infected cells and eliminate them by cell lysis.
The lysed virus-infected cells release viral antigens that are engulfed by APCs like dendritic cells, which display them with both MHC I and MHC II.
The antigen-MHC I complex is presented to antigen-specific naive CD8 T cells, which differentiate into cytotoxic T cells to kill virus-infected cells.
In contrast, the antigen-MHC II complex activates antigen-specific CD4 T cells, giving rise to helper T cells.
These cells enhance cytotoxic T cell activity for the destruction of infected cells.
Additionally, helper T cells activate B cells, whose receptors can directly bind free viral particles, differentiating into antibody-producing plasma cells.
These secreted antibodies bind other free viral particles, preventing them from penetrating target cells and marking them for neutralization by phagocytes.
View the full transcript and gain access to JoVE Core videos
Q1: What role do natural killer cells play in the initial immune response to viral infection?
Natural killer cells are activated by interferons secreted from infected cells and provide the first line of defense against viral pathogens. These cells possess pathogen recognition receptors that identify viral antigens on infected cells and eliminate them through cell lysis. NK cells also produce proinflammatory cytokines that help control viral disease progression.
Q2: How do CD8 T cells and CD4 T cells work together to eliminate virus-infected cells?
CD8 cytotoxic T cells recognize viral antigens presented on infected cells and directly kill them. CD4 helper T cells support this response by enhancing cytotoxic T cell activity and activating B cells to produce antibodies. This coordinated action ensures both direct elimination of infected cells and production of neutralizing antibodies against free viral particles.
Q3: What is the function of antibodies in protecting against viral infection?
Antibodies produced by plasma cells bind to free viral particles, preventing them from attaching to or penetrating target cells. This neutralization action stops viral spread and marks infected particles for destruction by phagocytes. Antibodies provide a critical layer of defense by blocking viral entry before infection can occur.
Q4: How do antigen-presenting cells contribute to the adaptive immune response against viruses?
Antigen-presenting cells like dendritic cells engulf viral antigens released from lysed infected cells and display them on their surface using both MHC I and MHC II molecules. MHC I complexes activate CD8 T cells to become cytotoxic killers, while MHC II complexes activate CD4 helper T cells. This dual presentation bridges innate and adaptive immunity.
Q5: What prevents an excessive immune response from causing tissue damage during viral infection?
Regulatory T cells control immune responses by suppressing overactive immune activity and limiting immunopathology. While a robust immune response is essential for clearing viral infections, regulatory T cells maintain balance to prevent the immune system from inadvertently damaging the body's own tissues during the fight against infection.
Q6: How does the innate immune response transition to the adaptive immune response during viral infection?
The innate response begins when interferons activate NK cells to kill infected cells. Viral antigens released from lysed cells are captured by antigen-presenting cells, which then activate antigen-specific T cells through MHC presentation. This transition from non-specific NK cell activity to specific T cell and B cell responses establishes adaptive immunity.
Q7: Why is understanding viral immune responses important for vaccine and therapy development?
Understanding how the immune system responds to viral pathogens through NK cells, T cells, and antibodies provides the foundation for designing effective vaccines and immunotherapies. Knowledge of antigen presentation, T cell activation, and antibody production enables researchers to develop interventions that enhance protective immunity while minimizing harmful immunopathology.